跳至主要内容
临床试验/NCT02792556
NCT02792556Unknown不适用

Evaluation of Urine Pregnancy Test, CHECK TOP Test, Compared to Transvaginal Ultrasound During Control Visit Post Drug Abortion (CHECK-TOP).

Hospices Civils de Lyon1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2016年9月最近更新:
适应症

试验速览

阶段
不适用
入组人数
300
试验地点
1
主要终点
Negative predictive value of urine pregnancy test CHECK TOP

研究概览

简要总结

According to a study of the DREES (Direction de la Recherche, des Etudes, de l'Evaluation et des Statistiques), in 2013, nearly 229 000 abortions were performed in France, an increasing number.

The success rate of drug abortion before 49 days of amenorrhea, defined by the National Health Autority as a complete abortion not requiring surgery, varies from 92 to 98% depending on the pregnancy term and the dose used.

The control visit is performed between the 14th day and the 21th day post abortion. Its role is to monitor the effectiveness of the method, to verify absence of complication and to better adapt contraception to prevent another unwanted pregnancy. The choice of the method is left to the physician's discretion: β-HCG dosage, pelvic or transvaginal ultrasound.

In the Orthogenic Departement of the Croix-Rousse Hospital Lyon, France, the method performed during the control visit is transvaginal ultrasound.

To simplify the monitoring of drug abortion, a urine pregnancy test would be an attractive alternative to transvaginal ultrasound: simplicity of use, speed, ease of interpretation and low cost.

The main objective of this study is to evaluate the diagnostic value of urine pregnancy test CHECK TOP compared to transvaginal ultrasound in monitoring the outcome of drug abortion during the control visit.

This is a monocentric observational study.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women ≥18 years of age
  • Undergoing drug abortion in Orthogenic Departement, Croix-Rousse Hospital, Lyon
  • Intrauterine pregnancy, single or multiple, until 8 weeks of amenorrhea
  • Agreeing to participate in the study after receiving information note
  • Affiliated to a social security system
  • Not subject to a measure of legal protection

排除标准

  • Women <18 years
  • Ineligible patient to drug abortion
  • Patient practicing a surgical abortion

结局指标

主要结局

Negative predictive value of urine pregnancy test CHECK TOP

时间窗: During control visit post drug abortion, after transvaginal ultrasound (at day14 or day21)

Negative predictive value of urine pregnancy test CHECK TOP taking as reference transvaginal ultrasound. A negative result at transvaginal ultrasound will be defined as the absence of ongoing pregnancy. An ongoing pregnancy is characterized by the presence of gestational sac, yolk sac and/or embryo with cardiac activity. A positive result will be retained only in case of ongoing pregnancy. Check Top test will be considered as negative if only one colored line appears in the control window, without any line in the result window. It will be considered as positive if two colored lines are present in the result window, corresponding to a β-HCG level \> 1000 IU/ml.

次要结局

  • Positive predictive value of urine pregnancy test Check Top(During control visit post drug abortion, after transvaginal ultrasound (at day14 or day21))
  • Sensibility of urine pregnancy test Check Top(During control visit post drug abortion, after transvaginal ultrasound (at day14 or day21))
  • Specificity of urine pregnancy test Check Top(During control visit post drug abortion, after transvaginal ultrasound (at day14 or day21))
  • Acceptability of urine pregnancy test Check Top by patients.(During control visit post drug abortion, after transvaginal ultrasound (at day14 or day21))

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验